1-Year Outcomes of Cardioband Tricuspid Valve Reconstruction System Early Feasibility Study-Reference-Cited by-同舟云学术

1-Year Outcomes of Cardioband Tricuspid Valve Reconstruction System Early Feasibility Study

Published:2022-10 Issue:19 Volume:15 Page:1921-1932
ISSN:1936-8798
Container-title:JACC: Cardiovascular Interventions
language:en
Short-container-title:JACC: Cardiovascular Interventions

Author:

Gray William A.,Abramson Sandra V.,Lim Scott,Fowler Dale,Smith Robert L.,Grayburn Paul A.,Kodali Susheel K.,Hahn Rebecca T.,Kipperman Robert M.,Koulogiannis Konstantinos P.,Eleid Mackram F.,Pislaru Sorin V.,Whisenant Brian K.,McCabe James M.,Liu Jin,Dahou Abdellaziz,Puthumana Jyothy J.,Davidson Charles J.,Feldman Ted,Gilmore Suzanne Y.,Krzmarzick Ann,Gerik Laura,Wang Vanessa,Cao Annie

Funder

Medtronic

Edwards Lifesciences

Abbott Laboratories

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference26 articles.

1. Tricuspid regurgitation is a public health crisis;Enriquez-Sarano;Prog Cardiovasc Dis,2019

2. Excess mortality associated with functional tricuspid regurgitation complicating heart failure with reduced ejection fraction;Benfari;Circulation,2019

3. Comparison of survival in patients with clinically significant tricuspid regurgitation with and without heart failure (from the Optum integrated file);Barker;Am J Cardiol,2021